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Abstract
The early host response to pathogens is mediated by several distinct pattern recognition receptors. Cytoplasmic RNA
helicases including RIG-I and MDA5 have been shown to respond to viral RNA by inducing interferon (IFN) production.
Previous in vitro studies have demonstrated a direct role for MDA5 in the response to members of the Picornaviridae,
Flaviviridae and Caliciviridae virus families ((+) ssRNA viruses) but not to Paramyxoviridae or Orthomyxoviridae ((2)s s R N A
viruses). Contrary to these findings, we now show that MDA5 responds critically to infections caused by Paramyxoviridae in
vivo. Using an established model of natural Sendai virus (SeV) infection, we demonstrate that MDA5
2/2 mice exhibit
increased morbidity and mortality as well as severe histopathological changes in the lower airways in response to SeV.
Moreover, analysis of viral propagation in the lungs of MDA5
2/2 mice reveals enhanced replication and a distinct distribution
involving the interstitium. Though the levels of antiviral cytokines were comparable early during SeV infection, type I, II, and III
IFN mRNA expression profiles were significantly decreased in MDA5
2/2 mice by day 5 post infection. Taken together, these
findings indicate that MDA5 is indispensable for sustained expression of IFN in response to paramyxovirus infection and
provide the first evidence of MDA5-dependent containment of in vivo infections caused by (2) sense RNA viruses.
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Introduction
Innate pathogen sensors detect viral products and respond by
initiating a signaling cascade that leads to rapid anti-viral response
involving secretion of type I IFNs (i.e. IFN-a and IFN-b) and
inflammatory cytokines (i.e. IL-6 and TNF-a) [1]. In particular,
type I IFNs restrict infection by inhibiting viral replication within
cells and by stimulating the innate and adaptive immune
responses. Once induced, secreted IFN-a and IFN-b bind to the
IFNa receptor on the cell surface in an autocrine or paracrine
manner. Activation of this receptor initiates the JAK/STAT signal
transduction pathways [2,3] and the expression of IFN-inducible
genes [4]. These gene products increase the cellular resistance to
viral infection and sensitize virally-infected cells to apoptosis [5]. In
addition, type I IFNs directly activate DC and NK cells, and
promote effector functions of T and B cells, thus providing a link
between the innate response to infection and the adaptive immune
response [6,7].
Several viral sensors have been identified that belong to the
Toll-like receptor (TLR) and RIG-I like receptor (RLR) families
[8]. TLRs are expressed on the cell surface and/or in endosomal
compartments [9]. TLR3 recognizes double stranded RNA
(dsRNA), a molecular pattern associated with replication of single
stranded RNA (ssRNA) viruses as well as the genomic RNA of
dsRNA viruses [10]. TLR7 and TLR8 recognize ssRNA
[9,11,12], whereas TLR9 recognizes unmethylated CpG-contain-
ing DNA [13]. RLRs are cytoplasmic proteins that recognize viral
nucleic acids that have gained access to the cytosol [14–19]. The
RLR family consists of three known members: retinoic acid-
inducible gene I (RIG-I), melanoma differentiation-associated
gene 5 (MDA5), and LGP2. RIG-I and MDA5 both contain a
DExD/H box helicase domain that binds dsRNA, a C-terminal
domain and two N-terminal caspase recruitment domains
(CARDs) that are involved in signaling [8,17,20,21]. LGP2
contains a helicase domain but lacks the CARDs, and its precise
contribution to antiviral signaling remains ambiguous [17,22].
Though RIG-I and MDA5 share common downstream
signaling via activation of IPS-1 (also called MAVS, VISA or
Cardif) and IRF3 [23–26], these helicases exhibit distinct substrate
specificity. In this regard, RIG-I has been shown to preferentially
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dsRNA molecules which are relatively short [29–31]. In contrast,
MDA5 recognizes long dsRNAs but does not discern 59
phosphorylation[30,32,33]. This distinct ligand preference has
been shown to confer specific recognition of individual viruses:
RIG-I has been shown to detect Influenza A and B viruses,
paramyxovirus, vesicular stomatitis virus (all (2) ssRNA virues)
and some Flaviviruses ((+) ssRNA viruses including Japanese
encephalitis virus, Hepatitis C virus and West Nile vi-
rus)[16,33,34]. In comparison, MDA5 has been shown to
selectively detect (+) ssRNA viruses including picornaviruses
(encephalomyocarditis virus, Mengo virus and Theilers virus)
[32,33], Caliciviridae (murine norovirus-1) [35], and Flaviridae (West
Nile Virus and Dengue Virus) [34,36]. Accordingly, it is believed
that the presence of different classes of sensors may reflect the need
for multiple mechanisms to effectively control the wide variety of
viral pathogens.
Paramyxoviruses are (2) ssRNA viruses that are responsible
for a number of human diseases including those caused by
measles, mumps, parainfluenza virus and respiratory syncytial
v i r u s( R S V ) .I m p o r t a n t l y ,i n f e c t i o n sc a u s e db yp a r a m y x o v i r u s e s
are the most frequent cause of serious respiratory illness in
childhood and are associated with an increased risk of asthma
[37,38]. Sendai virus (SeV) is am u r i n ep a r a i n f l u e n z av i r u s
which causes an acute respiratory disease in mice that resembles
severe paramyxoviral bronchiolitis found in humans following
RSV infection [39]. To date, RIG-I is the only dsRNA sensor
that has been implicated in the veritable detection of
paramyxoviruses [33,40]. The importance of RIG-I in the
containment of SeV infection is underscored by capacity of SeV
C proteins to directly antagonize RIG-I signaling [41] in
addition to their ability to inhibit IFN signal transduction
[42,43]. However, paramyxovirus-encoded V proteins are
known to directly interfere with MDA5 function by blocking
binding of dsRNA [14,44], thus implicating MDA5 in the
containment of paramyxovirus infection as well. In addition,
SeV defective interfering (DI) particles have been shown to
engage MDA5 in vitro [45], though the in vivo relevancy of this
detection mode is unknown. Thus, to determine whether MDA5
functions during natural infection with paramyxovirus in vivo,
we assessed mice deficient in MDA5 (MDA5
2/2 mice) following
respiratory tract infection with SeV.
Results
Infection with SeV causes increased morbidity and
mortality in MDA5
2/2 mice
In order to assess an in vivo role for MDA5 in containment
of paramyxovirus infection, we infected MDA5
2/2 mice with
Sendai virus (SeV). Mice on a C57BL/6 (B6) background were
selected for these experiments as the 129 strain is lethally
susceptible to SeV at extremely low inocula [46], thus
prohibiting assessment of loss of MDA5 function on this
background. A dose of 200,000 pfu was administered to mice
by intranasal delivery, an infection method that typically
results in acute, non-lethal bronchiolitis in B6 mice. As a gross
determinant of virus-induced morbidity, % body weight for
infected WT and MDA5
2/2 mice was monitored for 2 weeks
post infection (PI). Though essentially identical % weight loss
values were observed up until day 8 PI; onwards, weight loss in
MDA5
2/2 mice was significantly more severe (p,0.05)
(Figure 1A). Correspondingly, histological analysis of lung
sections obtained from day 12 PI MDA5
2/2 mice revealed
consolidation of the lung parenchyma as well as notable PAS-
positive airway cells, an indication of mucus hyper-secretion
(Figure 1B). Severe histopathology was not observed in the
lung sections obtained from control mice at this time point. In
addition, we compared survival following increasing inocula of
SeV (Figure 1C). Though MDA5
2/2 mice were not suscep-
tible to the 200K pfu SeV dose, MDA5
2/2 mice fully
succumbed to 400K and 600K pfu SeV, between 9–14 days
PI. In contrast, control mice were fully resistant to the 400K
pfu dose, though 40% mortality was observed for controls
infected with the 600K dose. Thus MDA5
2/2 mice exhibit
enhanced morbidity and susceptibility to SeV infection relative
to control mice.
To more fully assess SeV susceptibility, we extended our
analysis of the histological changes seen in the lungs of SeV-
infected MDA5
2/2 mice. H&E stained sections obtained from
day 2 PI (not shown) and day 5 PI (Figure 2A) lungs
demonstrated similar patterns of bronchiolitis, though peribron-
chiolar lymphoid cuffing that formed in the lungs of control mice
appeared moderately thicker and more densely populated than
those of MDA5
2/2 mice (Figure 2A). FACS analysis of lung-
derived leukocytes at d2, d5, and d8 PI revealed no significant
differences in lymphoid and myeloid subpopulations (neutrophils,
cDC, macrophage and alveolar macrophage; data not shown).
Significantly, at d5 and d8 PI, FACS analysis revealed equal
relative numbers of lymphoid subpopulations (CD3
+,C D 1 9
+ and
NK1.1
+); CD69 expression profiles on these subsets were
comparable between strains (data not shown). By d8-9 PI,
significant pathology was observed in the lungs of SeV-infected
MDA5
2/2 mice (Figure 2A), despite the fact that comparable
numbers of SeV-specific CTL were generated in both strains at
this time point (Figure 2B). Grossly, lungs dissected from SeV-
infected MDA5
2/2 mice exhibited enhanced areas of hemor-
rhage relative to control lungs (data not shown). Microscopic
analysis revealed epithelial cells that were notably hyperplastic
with abundant micropapillary projections. Additionally, severe
bronchointerstitial pneumonia was observed, with alveolar walls
adjacent to affected airways thickened and congested with
chronic inflammatory cell infiltrates and hyperplastic type II
pneumocytes, a lung injury pattern consistent with SeV
susceptibility [46,47]. In comparison, sections obtained from
control mice at these later time points exhibited moderate
changes to the airway epithelium and mild interstitial infiltration
(Figure 2A).
Author Summary
The innate immune system possesses an array of sensory
molecules which are purposed in detecting viral nucleic
acids. Our understanding of how these molecular sensors
detect viral nucleic acids continues to evolve. Herein, we
demonstrate that MDA5, a member of the RIG-I-like
receptor family, is involved in the detection of paramyxo-
virus infection in vivo. Specifically, MDA5 appears to
trigger antiviral cytokines that inhibit paramyxovirus
replication. In this regard, mice that are deficient in
MDA5 are unable to express sustained levels of these
cytokines and thus succumb to extensive viral propagation
and disease. Our findings are largely discordant from
previous in vitro studies using cultured cells, where it has
been shown that RIG-I and not MDA5 is involved in the
innate response to negative sense RNA viruses. Thus, our
data provides strong evidence of MDA5-based detection
of negative sense RNA viruses, and furthermore under-
score the importance of organism-based analysis of the
innate system.
MDA5 Detects Paramyxoviridae Infection
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2/2 mice demonstrate increased susceptibility to
SeV propagation
As susceptibility to SeV infection correlates with increased viral
burden [48], we next assessed viral replication in wild type and
MDA5
2/2 mice using a combined approach of real-time PCR
analysis and specific staining for SeV antigens. Initially, at d2 PI,
IF staining of viral antigens in lung sections appeared comparable
between the two strains. By d5 PI, SeV antigens exhibited
restrained expression in the airways of control mice (Figure 3A top
of panel). In contrast, the bronchioles of MDA5
2/2 mice
remained notably positive for SeV antigens at this time point
(Figure 3A bottom of panel). More striking however, was the
observation that parenchyma tissues proximal to infected airways
stained conspicuously for SeV antigens in MDA5
2/2 mice at d5
PI. In SeV resistant strains of mice, SeV infection is typically
restricted to the mucociliary epithelium of the conducting airways,
including the trachea, bronchi and bronchioles [49,50]. Viral
replication that extends to the alveolar spaces is a feature
commonly seen in susceptible strains of mice [51]. Accordingly,
this pattern of infection supports a role for MDA5 in controlling
the replication of SeV during in vivo infection.
To confirm this finding, we measured viral RNA levels from
WT and MDA5
2/2 mice infected with 200K pfu SeV using real-
time PCR analysis. Assessment was made using primer/probe sets
designed to amplify SeV genome (39 untranslated region) and SeV
N gene (genomic and transcript) (Figure 3B and C). Using this
strategy, an approximate 5 fold increase in SeV genome copy
number/Gapdh mRNA was detected on d5 PI, though significant
differences were also observed on d2 and d8 PI. Analysis of N gene
revealed ,2 fold increase in expression on days 2 and 5, though
there were no significant differences by d8 PI. Thus it appears that
MDA5 contributes in part to the containment of SeV replication
in vivo.
Cytokine response to SeV infection is altered in MDA5
2/2
mice
Though SeV is a potent inducer of type I IFN in the mouse,
functioning via several distinct pathways, it possesses several
mechanisms by which it can counteract the IFN response. Despite
this property, induction of IFN expression [14,52], particularly
type I and II, is critical in the containment of SeV infection in vivo
as underscored by the profound SeV susceptibility seen for mice
deficient in STAT1
2/2 mice [53]. As MDA5 is known to induce
expression of type I IFN in vitro in response to polyI:C stimulation
and viral infection [17], we sought to directly assess the ability of
MDA5
2/2 mice to express IFN in response to SeV infection. In
this regard, WT and MDA5
2/2 mice were infected with 200K pfu
SeV and subsequently assessed for cytokine expression by real-
time PCR analysis over the acute period. While both strains
demonstrated comparable mRNA levels at d2 PI, type I IFN
expression was dramatically dampened in MDA5
2/2 mice at d5
PI (Figure 4A and B). Unexpectedly, significant decreases in
expression of Ifn-c, Il-28b (Ifn-l3) and Tnf-a mRNA were also
observed in the lungs of MDA5
2/2 mice compared to the WT
cohort, with the most dramatic difference observed for Il-28b
mRNA expression (Figure 4C, D and E). In contrast, Il-1b, and Il-
Figure 1. Infection with SeV causes increased morbidity and mortality in MDA5
2/2 mice. WT and MDA5
2/2 mice were infected with 200K
pfu SeV and assessed for A) loss of body weight over the PI period and B) mucus production (PAS reactivity). C) WT and MDA5
2/2 mice were infected
with 200K, 400K and 600K pfu SeV and assessed for viability. N=4–16 mice, error bars refer to SEM, * P#0.05.
doi:10.1371/journal.ppat.1000734.g001
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though the levels of Il-6 mRNA was markedly increased in
MDA5
2/2 mice following infection (Figure 4F, G and H).
Accordingly, MDA5 appears to control the expression of SeV-
induced anti-viral cytokines, particularly type I, II and III IFNs,
during the late acute period (d5 PI), but does not appear to be
involved during the immediate early response. Importantly, the
decrease in IFN expression coincides with expanded viral
propagation in the MDA5
2/2 mice, suggesting that reduced
IFN expression during this time point accounts for the
corresponding increased viral burden.
Induction of IFN expression transactivates expression of a
number of IFN response genes through a signal transduction
cascade involving JAK/STAT activation. MDA5 and RIG-I are
among the genes induced by IFN signaling in vitro [20]. To
determine the expression profile of MDA5 and RIG-I in the
airways of mice infected with SeV, mRNA was measured by real-
time PCR analysis from whole lung homogenates obtained from
WT mice infected with 200K pfu SeV. Expression of Mda5 and
Rig-i mRNA was significantly increased at d2 and d5 PI, though
the levels began to decline by d8 PI (Figure 5A). Lastly, to
determine the tissue distribution of MDA5 expression, lung
sections from d5 PI mice were stained with anti-MDA5 polyclonal
antibodies. Visualization of MDA5-specific staining was per-
formed using tyramide-based amplification. IF microscopic
analysis of affected airways revealed a pattern of MDA5 expression
that was primarily restricted to the airway epithelium, though
expression was also detected in cells of the proximal interstitum, in
particular, in cells that appeared to resemble type II pneumocytes
and alveolar macrophage (Figure 5B). Sections from MDA5
2/2
mice did not stain for MDA5, confirming the specificity of anti-
MDA5 staining. Accordingly these findings indicate that MDA5 is
induced following SeV infection and that the lack of expression in
MDA5
2/2 mice accounts for the phenotype described at the later
time point.
Discussion
Our understanding of innate immune factors that recognize
and respond to pathogens has greatly expanded over the last
decade. A major component of the RNA virus detection system in
mammals involves members of the RLR family, including RIG-I,
MDA5, and LGP2 [1]. Elucidating a role for the RLRs in virus-
induced IFN production has been facilitated by the availability of
Figure 2. Increased histopathology in MDA5
2/2 mice. A) H&E micrographs of lung sections obtained from WT and MDA5
2/2 mice infected
with 400K pfu SeV on d5, d9, d12 PI. B) FACS analysis of lymphocytes derived from the lungs of WT and MDA5
2/2 mice, uninfected (top panels) and d5
post infected (bottom panels) stained with anti-CD8 and H-2K
b: FAPGNYPAL pentamer.
doi:10.1371/journal.ppat.1000734.g002
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2/2 and MDA5
2/2 mice [32,33]. Initial observations
using embryonic fibroblasts and bone marrow derived DCs
generated from these mice revealed striking phenotypes including
a failure to produce IFN in response to a wide cross-section of
viruses and nucleic acids, and an inability to contain viral
replication. Specifically, MDA5 was found to be the sole receptor
for picornaviruses and caliciviruses ((+) ssRNA viruses) [32,33,35],
whereas RIG-I was described as the receptor for (2) ssRNA
viruses such as paramyxoviruses and orthomyxoviruses, as well as
for (+) ssRNA viruses belonging to the Flaviridae family [16,33].
However, our understanding of these virus recognition systems in
vivo is limited, in part because RIG-I
2/2 mice die perinatally.
The precise molecular patterns of virus replication recognized
by RIG-I and MDA5 are still not fully clear. Initially, a mimic of
viral dsRNA, polyI:C, was found to bind and activate RIG-I.
However, ensuing research identified 59-triphosphate-linked
ssRNA as the major RIG-I inducer [27,28]. Furthermore, in vitro
data obtained using knockout mice suggested in fact that MDA5,
and not RIG-I, recognizes polyI:C, thereby formulating a
recognition model whereby RIG-I recognizes short 59-tripho-
sphorylated RNAs, while MDA5 recognizes dsRNA structures
irrespective of the 59 cap [8,30–32]. However, more thorough
dissection of the helicase binding function and activation process
has recently determined that the picture is indeed more complex
than previously thought [29,40]. In this regard, both helicases
have been shown to recognize dsRNA, in a manner that is likely
dependent on its length, while RIG-I demonstrates the added
ability to respond to 59-triphosphate ssRNA products. To
complicate these paradigms, there is increasing evidence that
viruses have evolved various properties aimed at antagonizing or
degrading viral sensors. Thus, our understanding of viral
recognition by the RLR helicases is evolving.
With respect to molecular sensing of paramyxovirus infection,
both 59-triphosphorylated ssRNA and long dsRNA species are
likely present in SeV-infected cells, thereby implicating both
MDA5 and RIG-I in the antiviral sensing process. However, in
vitro studies concur that cultured embryonic fibroblasts and bone
marrow-derived DC cells detect SeV RNA chiefly through RIG-I,
whereas MDA5 and TLR3 are dispensable [33,34,41,54]. TLR7
and TLR8 in myeloid cells have also been shown to recognize SeV
RNA in vitro as well [55]. Regardless, it cannot be excluded that
in vivo, other RNA sensors, including MDA5, may contribute, at
least in part, to anti-SeV responses. Indeed, a recent study by
Yount et al. has demonstrated that MDA5 can detect SeV DI
particles in vitro [45]. The relevancy of this recognition system in
vivo is uncertain; certainly in our hands, using SeV/52, which has
a limited ability to form DI particles, as per PCR-based analysis
(data not shown), MDA5 appears to exert a significant effect on
Figure 3. SeV replication is enhanced in MDA5
2/2 mice. WT and MDA5
2/2 mice infected with 200K pfu SeV were assessed for A) SeV
replication by IF detection of SeV antigens and by real time PCR analysis of B) SeV genome and C) SeV N gene expression. N=4, error bars refer to
SEM, * P,0.05; ** P,0.005.
doi:10.1371/journal.ppat.1000734.g003
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protein that specifically binds to and blocks MDA5 signaling in
vitro [14,44]. Thus, it is possible that MDA5 does, indeed, detect
SeV in vitro, but that it is functionally curtailed by the V protein in
this circumstance. Interestingly, in our hands, in vivo infections
using SeV with V protein deletion resulted in no real effect on
mortality or type I IFN induction across strains (data not shown),
likely explained by the fact that deletion of V protein in SeV
markedly attenuates virulence and pathogenicty in vivo [56].
While initial characterization of MDA5-deficient cells has not
supported a role for MDA5 in containment of SeV, these studies
have been limited to observations made in cultured embryonic
fibroblasts and in vitro-derived dendritic cells; populations which
are not primary targets for SeV replication in the course of the
natural infection. Rather, SeV replication mostly occurs in the
airway epithelium of the conducting airways [49,50]. For these
reasons, we hypothesized that SeV propagation would be sensitive
to the MDA5 status of the host in the context of an in vivo
infection. Indeed, the epithelial cells constitutively express MDA5
at low levels and subsequently up-regulate expression in response
to SeV (Figure 5B), a finding that supports the relevance of this
RNA helicase to SeV and other airborne infections. Interestingly,
MDA5 deficiency did not influence the composition of the
inflammatory infiltrate (data not shown), implying that the
immune defect is largely restricted to the airway epithelium, the
site of viral replication. This is compatible with our earlier findings
using STAT-1
2/2 chimeras, wherein we observed that loss of IFN
response in the stromal compartment alone accounted for the
immune deficiency to SeV [53]. We therefore sought to further
assess the significance of MDA5 in the control of SeV infection in
vivo. In this regard we have demonstrated that MDA5 controls
SeV replication and spread through induction of type I IFNs, but
that this effect appears late (d5 PI), as IFN gene transcription is not
impaired on d2 PI (Figure 4). It is likely that the initial IFN
response is sufficient to initiate a range of immune responses, such
that the late reduction in IFN transcripts results only in a 2–3 fold
change in LD50 (Figure 1). Whether this specific IFN pattern
remains true for other viruses as well remains to be tested. This
surprising collapse of the host type I IFN response at d5 PI is
accompanied by parallel decreases in the level of Il-28b and Tnf-a
expression (Figure 4), and, curiously, decreased Ifn-c transcript
levels. This later observation may reflect a selective role for MDA5
in the induction of IFN-c expression by NK cells. Lastly, the
MDA5 status does not appear to influence the levels of IL-1b,o r
IL-10 or the ability of the host to mount a virus-specific CTL
response. However, the levels of Il-6 mRNA in whole lung
Figure 4. MDA5 is required for sustained expression of cytokines in response to SeV infection. Real time PCR analysis of whole lung
homogenates obtained from WT and MDA5
2/2 mice infected with 200K pfu SeV for expression levels of A) Ifn-a2,B )Ifn-b,C )Ifn-c,D )Il-28b,E )Tnf-a,F )
Il-1b,G )Il-6 and H) Il-10 mRNA. N=4, error bars refer to SEM, * P,0.05, ** P,0.00001.
doi:10.1371/journal.ppat.1000734.g004
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2/2 was markedly
increased, suggesting the induction of compensatory mechanisms
in the context of MDA5 deficiency that could potentially account
for the enhanced morbidity and mortality seen in the MDA5
2/2
mice.
An additional concern raised by these data is the relative
contribution of MDA5 and RIG-I in the response to virus. In
light of the existing literature [33,40], it seems likely that RIG-I is
responsible for the normal IFN response to SeV early in the
infection. Indeed, as depicted in Figure 5A, RIG-I is strongly
induced early on during infection. Why the later IFN response
depends on MDA5 is not known. MDA5 is encoded by an IFN-
upregulated transcript, and it remains possible that it is the
accumulation of MDA5 that allows for the subsequent MDA5-
dependent IFN response on d5 PI. Yet other IFN-induced genes,
notably RIG-I, are also upregulated by IFN, which should
provide additional antiviral protection in vivo. Interestingly, SeV
encodes a nested set of C proteins that have been shown to
impede IFN signaling through direct inhibition of STAT
signaling [41,42] and which are also known to strongly
antagonize RIG-I function [41]. Furthermore, SeV-V proteins
have been shown to have direct inhibitory effects on both MDA5
and RIG-I signaling [41,44]. Thus it remains possible that the
effects of SeV V and C proteins have an accumulative effect on
RIG-I function that essentially overwhelms this sensor at d5 PI,
and that in this context, MDA5 plays an essential role in
containment of SeV. Since assessment of the relative contribution
of RIG-I and MDA5 in containment of SeV infection in vivo is
not possible, a possible next step in assessing the importance
of MDA5 function would involve assessment in MDA5
2/2 and
IPS-1
2/2 strains.
We envision several possibilities that could potentially explain
this dramatic effect of MDA5. The first is that, in the absence of
MDA5, the balance between virus replication and the IFN
response is disrupted sufficiently, such that by d5 PI, virus
replication has overwhelmed the response in a qualitative fashion
–presumably through direct cytotoxic effects or via the overpro-
duction of immunosuppressive C proteins. This possibility is
supported by the fact that SeV is replicating to higher levels in the
MDA5
2/2 lung already by d2 PI (Figure 3B). Indeed, in support
of this hypothesis, we observe a striking increase in SeV replication
that spreads extensively into the interstitium of MDA5
2/2 lungs
compared to controls. Another possible explanation, which we
have not assessed, is an apoptotic response potentially mediated by
MDA5. In this scenario, MDA5 would instruct or sensitize
infected cells to commit suicide so as to shut down viral replication
in infected cells. Indeed, ectopic expression of MDA5 in a
melanoma cell line has been shown to inhibit colony formation,
presumably through induction of apoptosis [20], and IPS-1
overexpression induces cell death, as well [57]. In fact, SeV-
dependent apoptotic signaling requires IRF3 [58]. In the case of
MDA5 deficiency, loss of pro-apoptotic activity could lead to a
robust increase in viral replication and enhanced IFN blockade
through overexpression of SeV C proteins. This possibility is
favored by the fact that, despite a normal IFN response on d2 PI
(Figure 4), the virus is found to be replicating at higher titers
(Figure 3B).
It seems likely that the inability of the MDA5
2/2 animals to
sustain an IFN response leads to increased viral replication and
dissemination on d5 PI, thus causing significantly higher morbidity
and mortality in the knockout cohort (Figure 1). It is important to
note, however, that the effects of MDA5 deficiency on SeV
Figure 5. Infection with SeV results in induction of antiviral sensor expression. A) Analysis of Mda5 and Rig-I mRNA expression in WT
mice during the acute SeV infection period as determined by real-time PCR analysis. B) Micrographs taken of lung sections obtained from WT and
MDA5
2/2 mice infected with 200K pfu SeV and stained for MDA5 expression. N=4, error bars refer to SEM, * P,0.05.
doi:10.1371/journal.ppat.1000734.g005
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target of the V protein. Indeed, SeV V mutants (SeV-DV) are
severely attenuated; replication is demonstrably abrogated in the
lungs by d2 PI [56]. IRF3 deficiency of the host restores SeV-DV
pathogenicity, suggesting that the mutant virus acts by blocking
IRF3 signaling [59]. Yet disease caused by SeV in MDA5
2/2
mice is milder than the disease seen in the IRF3
2/2 animals.
Consequently, we believe that the V protein must have additional
targets besides MDA5. In this regard, it has recently been
demonstrated that Lgp2 encodes a helicase epitope that is akin to
the MDA5 helicase, the portion of MDA5 that binds paramyxo-
virus V proteins [60], thereby suggesting that LGP2 may be an
additional V protein target. In this case, a MDA5-LGP2 double
knockout mouse may potentially phenocopy the IRF3 mutation in
its response to SeV infection.
Taken together, our findings demonstrate that MDA5 signifi-
cantly contributes to the response to paramyxovirus and constitute
the first in vivo demonstration of MDA5 activity against a negative-
strand virus. As such, it appears likely that MDA5 has a wider
specificity as a viral nucleic acid receptor than initially believed, and
that the initial clear-cut cases of either MDA5 or RIG-I being the
solereceptorfor a givenvirus will proveto beexceptions ratherthan
rules when studied in the context of in vivo infections.
Materials and Methods
Mouse generation, maintenance and infection
Control C57BL/6J (B6) mice used in these experiments were
purchased from JAX. MDA5
2/2 mice [32] were backcrossed onto
the B6 background to 99.9% congenicity. For in vivo SeV
infection, Sendai/52 Fushimi strain was instilled intranasally into
deeply anesthetized mice and at the indicated time points, mice
were humanly sacrificed for harvest of lung tissue. Virus was
purchased from the ATCC and subject to two rounds of in vitro
plaque purification in Vero cells to eliminate the presence of DI
particles. A clone thus identified was then subject to a single round
of amplification in embryonated chicken eggs following inocula-
tion of ,1000 PFU. 24–36 hr post inoculation, SeV was isolated
from the allantoic fluids and diluted in phosphate-buffered solution
to generate a viral stock that was subsequently characterized on
the basis of in vivo infectious properties. Calculation of PFU was
performed by standard plaque assay using either Vero E6 cells or
LLC-MK2 cells. Importantly, propagation under these conditions
does not favor the formation of DI particles, a process that occurs
most frequently when virus is repeatedly passaged at high MOI.
Indeed, PCR analysis of stock virus indicated the absence of DI
genomes. The methods for mice use and care were approved by
the Washington University Animal Studies Committee and are in
accordance with NIH guidelines.
FACS
Single cell lung suspensions were made from minced lung tissue
subjected to collagenase/hyaluronidase/DNAse I digestion. Stain-
ing of surface markers was performed using FcR block and
fluorochrome-conjugated mAbs. To immunophenotype the im-
mune infiltrate, specific combinations of mAbs were chosen which
discern granulocytes (Ly6G
+), macrophages (F4/80
+), cDC
(CD11c
+F4/80
2Siglec-H
2), pDC (Siglec-H
+ CD11c
mid), NK cells
(NK1.1
+NKp46
+), T cells (CD3
+CD4
+/2CD8
+/2) and B cells
(CD19
+). SeV-specific PE-labeled pentamer K
b:FAPGNYPAL
(NP 324-332) was purchased from Proimmune; cells were stained
with CD8 and counterstained with propidium iodide, F4/80 and
CD19 to eliminate background. Activation status was determined
using specific mAbs for MHC-II, NKG2D and CD69. Samples
were acquired on a FACScalibur (BD Biosciences) and analyzed
using Cellquest software.
Analysis of mRNA and virus-specific RNA
RNA was purified from lung homogenate using Trizol
Reagent (Invitrogen). RNA was treated with RNAse-free
DNAse I (Ambion) to eliminate genomic DNA. RNA was
converted to cDNA using the High-Capacity cDNA Archive
kit (Applied Biosystems). Target mRNA and viral RNAs were
quantified by real-time PCR using specific fluorogenic probes
and primers and the Fast Universal PCR Master Mix system
(Applied Biosystems). Primer sets and probes for mouse
Ifn-a2 (Mm00833961_s1), Ifn-b (Mm00439552_s1), Ifn-c
(Mm00801778-m1), Il-28b (Mm00663660_g1), Tnf-a
(Mm00443259_g1), Mda5 (Mm00459183_m1), Il-1b
(Mm00434227_g1), Il-6 (Mm00446190_m1), Il-10
(Mm00439616_m1) mRNA and SeV genome and Gapdh
mRNA were purchased from Applied Biosystems. Samples
were assayed on the 7500 Fast Real-Time PCR System and
analyzed using the 7500 Fast System Software (Applied
Biosystems). Levels of specific gene expression were standard-
ized to Gapdh mRNA expression levels.
Histology
Lungs were perfused and fixed with 4% paraformaldehyde.
Tissue was embedded in paraffin, cut into 5 um sections and
adhered to charged slides. Sections were deparaffinized in
Citrosolv (Fisherbrand), hydrated, and in the case of IF-
microscopy, treated to heat-activated antigen unmasking solution
(Vector Laboratories, Inc). H&E and PAS sections were visualized
by brightfield microscopy. Expression analysis was performed by
IF using chicken polyclonal anti-SeV (Jackson ImmunoResearch
Laboratories, Inc) and rabbit polyclonal anti-mouse MDA5
(Axxora Life Sciences, Inc). Biotinylated secondary antibodies
were purchased from Vector Laboratories, Inc). SeV and MDA5
expression was visualized using tyramide-based signal amplifica-
tion with Alexa Fluor 488 or 594 fluorochromes (Invitrogen).
Slides were counterstained with DAPI mounting media (Vector
Laboratories, Inc). Microscopy was performed using an Olympus
BX51 microscope.
Statistical analyses
Real-time PCR data was analyzed using an unpaired Student’s
t-test. If variances were unequal, Welch’s correction was applied.
Charted values represent mean 6 SEM. Survival statistics were
determined using by Kaplan-Meier analysis of paired cohorts. P
values below 0.05 were regarded as being significant for all
analyses. Experiments were repeated a minimum of three times.
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